Results 71 to 80 of about 3,210,025 (200)

Potential treatment methods targeting 2019-nCoV infection

, 2020
The novel coronavirus, 2019-nCoV, has quickly spread across the world and pose serious threat to public health because it can infect people very easily.
Huang, Jiamin, Liu, Shuwen, Selva Nandakumar, Kutty, Zhang, Lina, Cheng, Kui, Zheng, Lu   +5 more
core   +1 more source

Serological Predictors of Protection from Infection Upon Household Exposure to SARS‐CoV‐2

European Journal of Immunology, Volume 56, Issue 8, August 2026.
Household members of SARS‐CoV‐2 positive index persons donated a serum sample (t = 0). Within 14 days, the household members reported if COVID‐19‐like symptoms appeared and returned after 2 weeks to be retested. Serum responses were comprehensively measured and elevated variant‐specific IgA1 and neutralizing antibody responses identified in the ...
Henrike Maaß, Imke Hinrichs, Martina Pavletic, Manuela Harries, Tatjana Prinke, Najat Bdeir, Richard Egelkamp, Berit Lange, Yannic C. Bartsch, Mate Lerga, Luka Cicin‐Sain   +10 more
wiley   +1 more source

An interim review of the epidemiological characteristics of 2019 novel coronavirus

, 2020
OBJECTIVES: The 2019 novel coronavirus (2019-nCoV) from Wuhan, China is currently recognized as a public health emergency of global concern. METHODS: We reviewed the currently available literature to provide up-to-date guidance on control measures to be ...
Ryu, Sukhyun, Korean Society of Epidemiology 2019-nCoV Task Force Team, Chun, Byung Chul   +2 more
core   +1 more source

Retrospective Analysis of 2019-nCov-Infected Cases in Dongyang, Southeastern China

Canadian Journal of Infectious Diseases and Medical Microbiology, 2020
The 2019 novel coronavirus (2019-nCov) has caused increasing number of infected cases globally. This study was performed to analyze information regarding the transmission route and presence of viral nucleic acids on several clinical samples.
G. G. Li, Z. Lv, Y. S. Wang, J. F. Li, L. F. Feng, M. F. Wang, B. He, X. L. Pan   +7 more
doaj   +1 more source

Effectiveness, Safety, and Immunogenicity of a Second COVID‐19 Vaccine Booster in the Elderly: A Systematic Review and Meta‐Analysis Protocol

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background/Aims Older adults remain highly vulnerable to severe COVID‐19 outcomes due to immunosenescence and comorbidities. Although booster vaccination strategies have reduced hospitalizations and mortality, evidence regarding the effectiveness, safety, and immunogenicity of a second COVID‐19 vaccine booster dose in older adults remains ...
Marieli Thomazini Piske Garcia, Valeria Valim, Luís Carlos Lopes‐Júnior   +2 more
wiley   +1 more source

Wuhan coronavirus 2019-nCoV – what we can find out on a structural bioinformatics level

, 2020
Wuhan coronavirus 2019-nCoV – what we can find out on a structural bioinformatics levelThis is a preprint extracted from the website article. The current version is available at https://innophore.com/2019-ncov/.
Christian C. Gruber (8368620), Georg Steinkellner (8374919)   +1 more
core   +1 more source

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Emerging Microbes and Infections, 2020
A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as 2019 novel coronavirus (2019-nCoV) was announced by the World Health ...
Jasper Fuk-Woo Chan, Kin-Hang Kok, Zheng Zhu, Hin Chu, Kelvin Kai-Wang To, Shuofeng Yuan, Kwok-Yung Yuen   +6 more
doaj   +1 more source

Mobile Health Interventions to Support Patients With Dementia During the COVID‐19 Pandemic: A Systematic Review

Health Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background and Aims During the COVID‐19 pandemic, mobile health (mHealth) utilization increased, especially among specific groups such as patients with dementia (PwD). This systematic review aimed to assess mHealth interventions among PwD during the COVID‐19 pandemic. Methods This systematic review followed the PRISMA 2020 guidelines.
Parastoo Amiri, Neda Malek Mohammadi, Mohammad Sharifi, Ali Mohammadi, Hamid Sharifi, Zahra Galavi, Pooria Afsharifard   +6 more
wiley   +1 more source

SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV

Journal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT This study examined changes in anti‐Spike (anti‐S) antibodies (Abs) and type I interferon (IFN‐I) following the BNT162b2 vaccine in people living with HIV (PLWH) and analyzed the impact of demographic and immunological factors. In total, 75 PLWH and 28 healthy donors were followed at baseline (T0), at the second dose (T1), after the second ...
Federica Frasca, Luca Maddaloni, Alessandra D'Auria, Matteo Fracella, Ginevra Bugani, Carmen Falvino, Valentina Baccolini, Giuseppe Migliara, Francesca Aloisi, Letizia Santinelli, Enrico Palermo, Luca Bortolani, Alessandro Lazzaro, Giancarlo Ceccarelli, Ombretta Turriziani, Claudio Maria Mastroianni, Guido Antonelli, Gabriella d'Ettorre, Carolina Scagnolari   +18 more
wiley   +1 more source

Enhanced Immunogenicity and Cross‐Neutralizing Activity of a Trivalent Adenoviral Vector‐Based SARS‐CoV‐2 Vaccine in Mice

Journal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT The emergence of diverse SARS‐CoV‐2 Omicron subvariants has reduced the efficacy of existing vaccines, highlighting the need for multivalent vaccines with broader neutralizing capacity. We developed a trivalent adenoviral vector‐based vaccine (Ad5‐CoV19‐prototype/Delta/BF.7) encoding the spike proteins of the ancestral strain, Delta variant ...
Jianhua Li, Wanchen Song, Jiaxuan Li, Ruofan Peng, Chenghao Chen, Yanjun Zhang, Yonglan Zhu, Keda Chen   +7 more
wiley   +1 more source